These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2474480)
1. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480 [TBL] [Abstract][Full Text] [Related]
2. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication. Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436 [TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Weller IV J Hepatol; 1986; 3 Suppl 2():S107-10. PubMed ID: 2439568 [TBL] [Abstract][Full Text] [Related]
4. Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate. Hoofnagle JH J Hepatol; 1986; 3 Suppl 2():S73-80. PubMed ID: 2439579 [TBL] [Abstract][Full Text] [Related]
5. Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B. Buti M; Rodriguez-Frias F; Genesca J; Arranz A; Jardi R; Esteban R; Guardia J Liver; 1993 Jun; 13(3):136-40. PubMed ID: 7687734 [TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Hoofnagle JH; Hanson RG; Minuk GY; Pappas SC; Schafer DF; Dusheiko GM; Straus SE; Popper H; Jones EA Gastroenterology; 1984 Jan; 86(1):150-7. PubMed ID: 6196251 [TBL] [Abstract][Full Text] [Related]
7. Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication. Marcellin P; Pouteau M; Loriot MA; Boyer N; Degos F; Calès P; Bettan L; Bacq Y; Coppére H; Grange JD Gut; 1995 Mar; 36(3):422-6. PubMed ID: 7535285 [TBL] [Abstract][Full Text] [Related]
8. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial. Garcia G; Smith CI; Weissberg JI; Eisenberg M; Bissett J; Nair PV; Mastre B; Rosno S; Roskamp D; Waterman K Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633 [TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Weller IV; Lok AS; Mindel A; Karayiannis P; Galpin S; Monjardino J; Sherlock S; Thomas HC Gut; 1985 Jul; 26(7):745-51. PubMed ID: 2410328 [TBL] [Abstract][Full Text] [Related]
10. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy. Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580 [TBL] [Abstract][Full Text] [Related]
11. Prolonged inhibition of hepatitis B virus replication with vidarabine monophosphate in chronic active type B hepatitis. Guardia J; Esteban R; Buti M; Jardí R; Allende H; Esteban JI Liver; 1986 Apr; 6(2):118-22. PubMed ID: 2426552 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP). Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819 [TBL] [Abstract][Full Text] [Related]
13. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies. Scully LJ; Lever AM; Yap I; Pignatelli M; Thomas HC J Hepatol; 1986; 3 Suppl 2():S291-9. PubMed ID: 2439575 [TBL] [Abstract][Full Text] [Related]
14. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. Perrillo RP J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421 [TBL] [Abstract][Full Text] [Related]
16. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates. Thomas HC; Scully LJ; Lever AM; Yap I; Pignatelli M Infection; 1987; 15 Suppl 1():S26-31. PubMed ID: 2439462 [TBL] [Abstract][Full Text] [Related]
17. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis. Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183 [TBL] [Abstract][Full Text] [Related]
18. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection. Brook MG; Petrovic L; McDonald JA; Scheuer PJ; Thomas HC J Hepatol; 1989 Mar; 8(2):218-25. PubMed ID: 2469711 [TBL] [Abstract][Full Text] [Related]
19. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774 [TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate. Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]